Randomized trial of indocyanine green dosing and timing for near-infrared fluorescent cholangiography in laparoscopic cholecystectomy

Phase 4, randomised, open-label trial of indocyanine green in gallbladder disease, cholelithiasis and cholecystitis (2 arms), sponsored by Hospital Universitario de Salamanca. Primary endpoint: Identification of biliary structures prior to dissection of the hepatocystic triangle. Started Mar 2022; status: active.